Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Atara Biotherapeutics, Inc. (ATRA)  
$0.39 0.00 (0.00%) as of 4:30 Tue 6/18


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 108,674,000
Market Cap: 42.88(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.2298 - $2.31
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  707
Guru Rank Value     : 1.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Atara Biotherapeutics is engaged in T-cell immunotherapy, using its allogeneic Epstein-Barr virus (EBV) T-cell platform to develop therapies for patients with diseases, including tumors, hematologic cancers and autoimmune disease. Co.'s platform utilizes the biology of EBV T cells and has the capability to treat a range of EBV-driven diseases or other diseases through incorporation of engineered chimeric antigen receptors or T-cell receptors. Co.'s T-cell immunotherapy program, tab-cel® (tabelecleucel), is partnered with Pierre Fabre Medicament and is in Phase 3 development for patients with EBV-driven post-transplant lymphoproliferative disease.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 816,825 816,825
Total Buy Value $0 $0 $194,885 $194,885
Total People Bought 0 0 3 3
Total Buy Transactions 0 0 4 4
Total Shares Sold 211,204 267,396 419,842 591,605
Total Sell Value $130,313 $170,773 $340,560 $980,941
Total People Sold 5 5 6 9
Total Sell Transactions 5 10 23 41
End Date 2024-03-28 2023-12-26 2023-06-27 2022-06-27

   
Records found: 736
  Page 28 of 30  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Haqq Christopher Chief Medical Officer   •       –      –    2015-08-17 4 AS $45.75 $73,632 D/D (1,604) 245,890     -
   Haqq Christopher Chief Medical Officer   •       –      –    2015-08-17 4 OE $0.00 $0 D/D 829 247,494     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2015-08-17 4 OE $0.00 $0 D/D 5,907 41,532     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2015-07-31 4 AS $55.41 $146,214 I/I (2,600) 380,182     -
   Haqq Christopher Chief Medical Officer   •       –      –    2015-07-31 4 AS $55.43 $138,575 D/D (2,500) 246,665     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2015-07-30 4 AS $56.05 $145,946 I/I (2,600) 382,782     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2015-07-17 4 AS $59.90 $156,388 I/I (2,600) 385,382     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2015-07-16 4 AS $60.90 $159,292 I/I (2,600) 387,982     -
   Haqq Christopher Chief Medical Officer   •       –      –    2015-07-15 4 AS $62.73 $157,353 D/D (2,500) 249,165     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2015-07-01 4 AS $45.25 $124,544 I/I (2,600) 390,582     -
   Haqq Christopher Chief Medical Officer   •       –      –    2015-07-01 4 AS $50.94 $129,196 D/D (2,500) 251,665     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2015-06-30 4 AS $51.65 $137,616 I/I (2,600) 393,182     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2015-06-18 4 AS $52.62 $141,465 I/I (2,600) 395,782     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2015-06-17 4 AS $54.86 $143,080 I/I (2,600) 398,382     -
   Mcgrath John Chief Financial Officer   •       –      –    2015-06-15 4 AS $50.00 $500,000 D/D (10,000) 27,352     -
   Haqq Christopher Chief Medical Officer   •       –      –    2015-06-15 4 AS $44.56 $348,116 D/D (7,500) 254,165     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2015-06-05 4 AS $43.74 $114,685 I/I (2,600) 400,982     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2015-06-04 4 AS $41.22 $159,911 I/I (3,800) 403,582     -
   Haqq Christopher Chief Medical Officer   •       –      –    2015-06-01 4 AS $40.95 $103,665 D/D (2,500) 261,665     -
   Mcgrath John Chief Financial Officer   •       –      –    2015-05-29 4 AS $40.00 $400,000 D/D (10,000) 37,352     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2015-05-22 4 AS $37.40 $75,256 I/I (2,000) 407,382     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2015-05-21 4 AS $37.06 $74,966 I/I (2,000) 409,382     -
   Seidenberg Beth C Director   –       •       •   2015-05-19 4 D $0.00 $0 I/I (300,000) 63,122     -
   Kpcb Xv Founders Fund, Llc 10% Owner   –       –       •   2015-05-19 4 D $0.00 $0 I/I (300,000) 63,122     -
   Ciechanover Isaac E. Chief Executive Officer   •       •      –    2015-05-15 4 GA $0.00 $0 I/I 19,082 411,382     -

  736 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 28 of 30
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed